Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

TRIM24 links a non-canonical histone signature to breast cancer.

Nature | 2010

Recognition of modified histone species by distinct structural domains within 'reader' proteins plays a critical role in the regulation of gene expression. Readers that simultaneously recognize histones with multiple marks allow transduction of complex chromatin modification patterns into specific biological outcomes. Here we report that chromatin regulator tripartite motif-containing 24 (TRIM24) functions in humans as a reader of dual histone marks by means of tandem plant homeodomain (PHD) and bromodomain (Bromo) regions. The three-dimensional structure of the PHD-Bromo region of TRIM24 revealed a single functional unit for combinatorial recognition of unmodified H3K4 (that is, histone H3 unmodified at lysine 4, H3K4me0) and acetylated H3K23 (histone H3 acetylated at lysine 23, H3K23ac) within the same histone tail. TRIM24 binds chromatin and oestrogen receptor to activate oestrogen-dependent genes associated with cellular proliferation and tumour development. Aberrant expression of TRIM24 negatively correlates with survival of breast cancer patients. The PHD-Bromo of TRIM24 provides a structural rationale for chromatin activation through a non-canonical histone signature, establishing a new route by which chromatin readers may influence cancer pathogenesis.

Pubmed ID: 21164480 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NIDDK NIH HHS, United States
    Id: P30DK078392-01
  • Agency: NICHD NIH HHS, United States
    Id: T32 HD07325
  • Agency: NIGMS NIH HHS, United States
    Id: GM081627
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK078392
  • Agency: NICHD NIH HHS, United States
    Id: T32 HD007325
  • Agency: NIGMS NIH HHS, United States
    Id: P01 GM081627
  • Agency: NIGMS NIH HHS, United States
    Id: P01 GM081627-010003
  • Agency: NIBIB NIH HHS, United States
    Id: P30 EB009998
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM079641
  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR000077
  • Agency: NCRR NIH HHS, United States
    Id: U54 RR025216
  • Agency: NIGMS NIH HHS, United States
    Id: P01 GM081627-020003
  • Agency: NIGMS NIH HHS, United States
    Id: GM079641

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


MCF-7 (tool)

RRID:CVCL_0031

Cell line MCF-7 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions